Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New artemisinin technologies to boost antimalarial supplies

This article was originally published in Scrip

Executive Summary

Three new technologies to boost the supply of artemisinin-based antimalarials were described at a conference on The Artemisinin Enterprise held recently at the University of York, UK. They include improved plant breeding, novel synthetic biology approaches, and the identification of new peroxide derivatives, the meeting heard. The Artemisinin Enterprise is a joint collaboration of the Institute for OneWorld Health (iOWH), the Centre for Novel Agricultural Products at the University of York, UK, and the Medicines for Malaria Venture.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts